Kali Therapeutics Named to the 2026 Endpoints 11, Recognizing Biotech's Most Promising Startups
SAN MATEO, Calif., Sept. 25, 2026 /PRNewswire/ -- Kali Therapeutics, a clinical-stage biotechnology company pioneering next-generation immune-resetting and multi-specific therapies, today announced its selection as a winner of the 2026 Endpoints 11, the annual list of the 11 most...
Short extract only — this publisher licenses its text. Read the full release at the source.
More from Commercial newswire
- nuHarbor Expands Splunk Practice with New mXDR Offering
- Guillermo Ochoa je tváří nové kampaně, která podporuje závazek společnosti BC.Game k regulovanému mexickému trhu
- Wriggle Box LLC Launches Indiegogo Campaign for 'Wriggleworm,' a Breakthrough Full-Body Sensory Regulation Play Structure
The rest of this wire is for subscribers
Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
7 days, no card required.
Read releases like this the second they cross the wire.
1,400+ feeds — live on PPN World right now. Every release from this source, the moment it crosses — plus 80+ other newswires, saved searches and instant alerts.
Start the free trial →Your announcement next? Distribute your press release to the global wires with PPN Source — and track its pickup live here.
PPN Source →